These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15203726)

  • 1. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
    Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
    Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
    Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
    Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
    Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
    Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system.
    Rushing EJ; Armonda RA; Ansari Q; Mena H
    Cancer; 1996 May; 77(9):1884-91. PubMed ID: 8646689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
    Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
    Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
    Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
    J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
    Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
    Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
    Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
    Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
    Oshima CT; Iriya K; Forones NM
    Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
    Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
    J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.
    Cordes C; Münzel AK; Rudolph P; Hoffmann M; Leuschner I; Gottschlich S
    Anticancer Res; 2009 Apr; 29(4):1459-65. PubMed ID: 19414402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal chondrosarcoma. An immunohistochemical study.
    Swanson PE; Lillemoe TJ; Manivel JC; Wick MR
    Arch Pathol Lab Med; 1990 Sep; 114(9):943-8. PubMed ID: 2202275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.